AbstractMantle cell lymphoma (MCL) and peripheral T cell lymphoma (PTCL) are distinct lymphoma subtypes that each comprise about ∼10% of the non-Hodgkin lymphomas. Although both subtypes are characterized by high remission rates to frontline chemotherapy, the prognosis is generally poor because of inevitable relapse within 1-2 years or less, depending on the specific histology. Patients with MCL who achieve a complete remission with upfront conventional chemotherapy currently have several options for consolidative therapy including maintenance therapy with rituximab, autologous hematopoietic cell transplantation (HCT), and more recently, allogeneic HCT utilizing a reduced intensity conditioning (RIC) regimen. In the autologous HCT setting, ...
peer reviewedWhilst autologous stem cell transplantation (auto-SCT) is considered standard of care f...
Autologous transplantation of peripheral blood (PB) hematopoietic stem cells (HSCs) is a widely used...
AbstractPatients with chemorefractory mantle cell lymphoma (MCL) have a poor prognosis. We used the ...
AbstractMantle cell lymphoma (MCL) and peripheral T cell lymphoma (PTCL) are distinct lymphoma subty...
AbstractThe peripheral T cell lymphomas (PTCL) carry a worse prognosis compared to B cell non-Hodgki...
Patients with peripheral T cell lymphoma (PTCL) have a poor prognosis with current treatment approac...
Reduced-intensity allogeneic stem cell transplantation (RIC-AlloSCT) is being increasingly considere...
peer reviewedBackground: Peripheral T cell lymphomas form a heterogeneous group with a usually disma...
Peripheral T-cell lymphomas are a heterogeneous group of rare diseases with an aggressive behavior a...
Peripheral T-cell lymphomas are a heterogeneous group of rare diseases with an aggressive behavior a...
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare diseases, characterized by an ...
Importance: Maintenance therapies are often considered as a therapeutic strategy in patients with ly...
Autologous (auto-) and allogeneic (allo-) hematopoietic cell transplantation (HCT) are accepted trea...
Current guidelines recommend consolidation with autologous stem cell transplantation (autoSCT) after...
AbstractThe purpose of this study was to analyze the impact of graft-versus-host disease (GVHD) on t...
peer reviewedWhilst autologous stem cell transplantation (auto-SCT) is considered standard of care f...
Autologous transplantation of peripheral blood (PB) hematopoietic stem cells (HSCs) is a widely used...
AbstractPatients with chemorefractory mantle cell lymphoma (MCL) have a poor prognosis. We used the ...
AbstractMantle cell lymphoma (MCL) and peripheral T cell lymphoma (PTCL) are distinct lymphoma subty...
AbstractThe peripheral T cell lymphomas (PTCL) carry a worse prognosis compared to B cell non-Hodgki...
Patients with peripheral T cell lymphoma (PTCL) have a poor prognosis with current treatment approac...
Reduced-intensity allogeneic stem cell transplantation (RIC-AlloSCT) is being increasingly considere...
peer reviewedBackground: Peripheral T cell lymphomas form a heterogeneous group with a usually disma...
Peripheral T-cell lymphomas are a heterogeneous group of rare diseases with an aggressive behavior a...
Peripheral T-cell lymphomas are a heterogeneous group of rare diseases with an aggressive behavior a...
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare diseases, characterized by an ...
Importance: Maintenance therapies are often considered as a therapeutic strategy in patients with ly...
Autologous (auto-) and allogeneic (allo-) hematopoietic cell transplantation (HCT) are accepted trea...
Current guidelines recommend consolidation with autologous stem cell transplantation (autoSCT) after...
AbstractThe purpose of this study was to analyze the impact of graft-versus-host disease (GVHD) on t...
peer reviewedWhilst autologous stem cell transplantation (auto-SCT) is considered standard of care f...
Autologous transplantation of peripheral blood (PB) hematopoietic stem cells (HSCs) is a widely used...
AbstractPatients with chemorefractory mantle cell lymphoma (MCL) have a poor prognosis. We used the ...